Surgical resection of lung adenocarcinoma after crizotinib treatment: Report of a case

Kaoru Kaseda, Ken Ichi Watanabe, Keisuke Asakura, Akio Kazama

研究成果: Article査読

2 被引用数 (Scopus)

抄録

A 45-year-old female was diagnosed as having lung adenocarcinoma harboring an anaplastic lymphoma kinase (ALK) rearrangement, stage IV (T2bN3M1b). She was treated with crizotinib as second-line chemotherapy. The clinical stage after crizotinib treatment was ycT2aN0M0, stage IB. We performed a left lower lobectomy and lymph node dissection aimed at local control and pathological confirmation of the remaining tumor. The final pathological stage was ypT2aN2M0, stage IIIA with Ef 1b. To the best of our knowledge, this is the first case report of surgical resection in ALK rearrangement-positive lung adenocarcinoma after crizotinib treatment.

本文言語English
論文番号74
ジャーナルWorld Journal of Surgical Oncology
13
1
DOI
出版ステータスPublished - 2015 2 22

ASJC Scopus subject areas

  • Surgery
  • Oncology

フィンガープリント 「Surgical resection of lung adenocarcinoma after crizotinib treatment: Report of a case」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル